Lenvatinib for the treatment of kidney cancer

Studentova, H; Vitaskova, D; Melichar, B

Melichar, B (reprint author), Palacky Univ, Med Sch, Dept Oncol, IP Pavlova 6, Olomouc 77520, Czech Republic.; Melichar, B (reprint author), Teaching Hosp, IP Pavlova 6, Olomouc 77520, Czech Republic.

EXPERT REVIEW OF ANTICANCER THERAPY, 2018; 18 (6): 511

Abstract

Introduction: Sequential administration of single targeted agents has evolved as the dominant paradigm in advanced RCC treatment. Lenvatinib plus ever......

Full Text Link